Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium carbonate and chloride, ammonium chloride, and bicarbonate food and feed additives; industrial grade potassium carbonate and bicarbonate; and agricultural and industrial grade ammonium chloride. It also provide… Read more
Zhejiang Dayang Biotech Group Co (003017) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.001x
Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K) by net assets (CN¥1.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Dayang Biotech Group Co - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Shineway Pharmaceutical Group Limited
PINK:CSWYF
|
0.113x |
|
Sam Engineering Equipment
KLSE:9822
|
0.021x |
|
Television Broadcasts Ltd
PINK:TVBCY
|
0.104x |
|
Xiamen East Asia Machinery Industrial Co. Ltd.
SHE:301028
|
N/A |
|
EQUALS GROUP PLC LS-01
F:2FX
|
N/A |
|
Guangzhou Jointas Chemical Joint Stock Co Ltd
SHE:002909
|
0.006x |
|
Contrel Technology Co Ltd
TWO:8064
|
0.011x |
|
AUTOHELLAS S.A.NA EO 108
F:0AH1
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.05 Billion | CN¥66.19 Million | 0.063x | -65.26% |
| 2023-12-31 | CN¥1.01 Billion | CN¥182.42 Million | 0.181x | +93.97% |
| 2022-12-31 | CN¥985.05 Million | CN¥91.89 Million | 0.093x | +362.87% |
| 2021-12-31 | CN¥990.71 Million | CN¥-35.16 Million | -0.035x | -130.23% |
| 2020-12-31 | CN¥958.13 Million | CN¥112.49 Million | 0.117x | -48.29% |
| 2019-12-31 | CN¥498.09 Million | CN¥113.09 Million | 0.227x | +158.02% |
| 2018-12-31 | CN¥440.62 Million | CN¥38.77 Million | 0.088x | -38.90% |
| 2017-12-31 | CN¥337.71 Million | CN¥48.64 Million | 0.144x | -60.97% |
| 2016-12-31 | CN¥229.35 Million | CN¥84.63 Million | 0.369x | +58.13% |
| 2015-12-31 | CN¥209.76 Million | CN¥48.95 Million | 0.233x | -20.42% |
| 2014-12-31 | CN¥196.87 Million | CN¥57.73 Million | 0.293x | -40.03% |
| 2013-12-31 | CN¥187.42 Million | CN¥91.64 Million | 0.489x | -- |